Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Vaxcyte, Inc.

NASDAQ: PCVX · Life Sciences · 10 alerts · CIK 1649094

Share price
$61.61Close, Nov 16
Market cap
$9.75B
Shares outstanding
158.3MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Vaxcyte, Inc. filings on SEC EDGAR ↗

4:43 PM ET 8-K
Loan & Debt

Vaxcyte $575M Debt Financing with U.S. Bank Trust Company, National Association

Vaxcyte, Inc. completed the sale and issuance of $575 million in 1.50% Convertible Senior Notes due 2032. The notes are senior unsecured obligations with an initial conversion price of approximately $89.60 per share of common stock. The company intends to use the proceeds for general corporate purposes, which may include research and development and working capital.

Value
$575M
Counterparty
U.S. Bank Trust Company, National Association
Term
through Oct 2032

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.